MedTrace Logo

Fitness, Ageing, and Bilingualism (FAB): The Benefits of Regular Exercise and Bilingualism for Language Abilities in Healthy Ageing.

NCT07443189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2026-03-02

No results posted yet for this study

Summary

This project investigates the relative benefits of regular physical activity and bilingualism for ameliorating cognitive decline in healthy ageing, with a particular focus on language function. The randomized intervention component tests whether improving fitness via a home-based HIIT program leads to changes in fitness and related cognitive/language outcomes in older adults.

Conditions

Interventions

OTHER

Home-Based HIIT

Participants will complete a 26-week home-based HIIT program comprising simple circuit training once per week and interval training twice per week. A 26-week dose will be targeted; if interruptions occur (e.g., illness, travel), the intervention period will be extended to ensure completion of 26 weeks of exercise sessions. The first four weeks will constitute a familiarization period with sub-maximal sessions, training equipment familiarization (Polar Unite watch and Polar H9 chest sensor), and instructional videos. Subsequent sessions will target high intensity (≥80% of HRpeak). Training will be guided by a personal exercise coach via emails, phone calls, and face-to-face meetings once weekly during the familiarization period and monthly thereafter. Participants will use a Polar Unite watch and Polar H9 chest sensor; the watch will be pre-programmed to display %HRpeak in real time during sessions. Exercise data will be extracted using Polar Flow software.

Sponsors & Collaborators

  • University of Birmingham

    collaborator OTHER

  • University of Agder

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Norway
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07443189 on ClinicalTrials.gov